Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection
暂无分享,去创建一个
D. Margolis | N. Archin | C. Garrido | J. Kuruc | Noelle P. Dahl | N. Soriano-Sarabia | Rosalie Bateson | A. Crooks
[1] Nancie M Archin,et al. Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies. , 2015, The Journal of infectious diseases.
[2] D. Margolis,et al. Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4+ T Cells , 2014, Journal of Virology.
[3] H. Hatano,et al. Occurrence of etravirine/rilpivirine-specific resistance mutations selected by efavirenz and nevirapine in Kenyan patients with non-B HIV-1 subtypes failing antiretroviral therapy , 2014, AIDS.
[4] C. Johnson,et al. Effects of a Range-Expanding Sea Urchin on Behaviour of Commercially Fished Abalone , 2013, PLoS ONE.
[5] Jeffrey N. Martin,et al. Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers , 2013, AIDS.
[6] Douglas D. Richman,et al. Highly Precise Measurement of HIV DNA by Droplet Digital PCR , 2013, PloS one.
[7] R. Siliciano,et al. Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies , 2013, PLoS pathogens.
[8] H. Jomaa,et al. Primary MHC-Class II+ Cells Are Necessary To Promote Resting Vδ2 Cell Expansion in Response to (E)-4-Hydroxy-3-Methyl-But-2-Enyl-Pyrophosphate and Isopentenyl Pyrophosphate , 2012, The Journal of Immunology.
[9] A. Perelson,et al. Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection , 2012, Proceedings of the National Academy of Sciences.
[10] Haishan Li,et al. HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDS. , 2011, Blood.
[11] Zheng W. Chen. Immune biology of Ag-specific γδ T cells in infections , 2011, Cellular and Molecular Life Sciences.
[12] Guido Ferrari,et al. Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy , 2011, PloS one.
[13] D. Kabelitz. γδ T-cells: cross-talk between innate and adaptive immunity , 2011, Cellular and Molecular Life Sciences.
[14] J. Lifson,et al. Mechanisms underlying γδ T-cell subset perturbations in SIV-infected Asian rhesus macaques. , 2010, Blood.
[15] N. Romani,et al. CD56+ human blood dendritic cells effectively promote TH1-type gammadelta T-cell responses. , 2009, Blood.
[16] M. Bonneville,et al. Early Triggering of Exclusive IFN-γ Responses of Human Vγ9Vδ2 T Cells by TLR-Activated Myeloid and Plasmacytoid Dendritic Cells1 , 2009, The Journal of Immunology.
[17] S. Bernacchi,et al. Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors , 2009, Microbiology and Molecular Biology Reviews.
[18] Jean-Saville Cummings,et al. Impacts of HIV infection on Vγ2Vδ2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS , 2008, Journal of leukocyte biology.
[19] J. Coffin,et al. Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells , 2008, AIDS.
[20] M. Bonneville,et al. Potentiation of Antigen-Stimulated Vγ9Vδ2 T Cell Cytokine Production by Immature Dendritic Cells (DC) and Reciprocal Effect on DC Maturation1 , 2006, The Journal of Immunology.
[21] R. Redfield,et al. Association between longer duration of HIV-suppressive therapy and partial recovery of the V gamma 2 T cell receptor repertoire. , 2004, The Journal of infectious diseases.
[22] F. Poccia,et al. Differentiation of Effector/Memory Vδ2 T Cells and Migratory Routes in Lymph Nodes or Inflammatory Sites , 2003, The Journal of experimental medicine.
[23] R. Siliciano,et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells , 2003, Nature Medicine.
[24] C. Leen,et al. Phenotypic analysis of peripheral blood gammadelta T lymphocytes and their targeting by human immunodeficiency virus type 1 in vivo. , 2003, Virology.
[25] M. Malim,et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.
[26] M. Goldman,et al. Human γδ T Cells Induce Dendritic Cell Maturation , 2002 .
[27] J. Wiesner,et al. Identification of (E)‐4‐hydroxy‐3‐methyl‐but‐2‐enyl pyrophosphate as a major activator for human γδ T cells in Escherichia coli , 2001 .
[28] H. Lichtenthaler,et al. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. , 1999, Science.
[29] F. Poccia,et al. Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. , 1999, The Journal of infectious diseases.
[30] J. Lisziewicz,et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.
[31] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[32] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[33] F. Poccia,et al. Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons. , 1996, Journal of immunology.
[34] S. Bartz,et al. γδ T lymphocyte responses to HIV , 1996 .
[35] B. Bloom,et al. Natural and synthetic non-peptide antigens recognized by human γδ T cells , 1995, Nature.
[36] A. Garzino-Demo,et al. Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection , 1995, The Journal of experimental medicine.
[37] Y. Tanaka,et al. Nonpeptide ligands for human gamma delta T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[38] T. Miyawaki,et al. Differential expression of CD45RO (UCHL1) and its functional relevance in two subpopulations of circulating TCR-gamma/delta+ lymphocytes , 1990, The Journal of experimental medicine.
[39] M. Stevenson,et al. HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.
[40] C. Katlama,et al. T cell receptor gamma/delta+ lymphocyte subsets during HIV infection. , 1989, Clinical and experimental immunology.
[41] M. Bonneville,et al. Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. , 2006, Journal of immunology.
[42] R. Siliciano,et al. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. , 2005, Methods in molecular biology.
[43] M. Goldman,et al. Human gamma delta T cells induce dendritic cell maturation. , 2002, Clinical immunology.
[44] J. Wiesner,et al. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli. , 2001, FEBS letters.
[45] A. Hayday. [gamma][delta] cells: a right time and a right place for a conserved third way of protection. , 2000, Annual review of immunology.
[46] H. Kiyono,et al. Functional γδ T-lymphocyte Defect Associated with Human Immunodeficiency Virus Infections , 1997, Molecular medicine.
[47] Y. Tanaka,et al. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. , 1995, Nature.